期刊文献+

肿瘤大数据在抗肿瘤药物应用中的研究进展 被引量:6

Research progress on tumor big data in the application of anti-tumor medicine
原文传递
导出
摘要 世界范围内肿瘤大数据已经取得了长足的进步,总结了肿瘤大数据在抗肿瘤药物应用中的研究进展,包括肿瘤流行病学、肿瘤早期诊断、新靶点和新适应症的发现、不良反应的信号发掘、患者预后模型的构建,以及肿瘤大数据存在的不足,如数据的采集、可信度、保存、安全性等。 Tumor big data has made great progress worldwide. The research progress of tumor big data in the application of tumor medicine including tumor epidemiology, early diagnosis, the discovery of new target and indications, signal discovery of adverse reactions, construction of patient prognosis model, and the shortage of tumor big data such as data collection, reliability, storage, and security, etc was summarized in this paper.
作者 周海辉 张海霞 严婷婷 葛卫红 ZHOU Hai-hui;ZHANG Hai-xia;YAN Ting-ting;GE Wei-hong(Division of Clinical Pharmacy,Department of Pharmacy,Drum Tower Hospital Affiliated to Medical School of Nanjing University,Nanjing 210008,China;Cancer Center,Drum Tower Hospital Affiliated to Medical School of Nanjing University,Nanjing 210008,China)
出处 《现代药物与临床》 CAS 2018年第11期3079-3082,共4页 Drugs & Clinic
基金 国家自然科学基金资助项目(81601153) 江苏省自然科学基金资助项目(BK20150104) 南京市医学科技发展基金资助项目(YKK16083) 南京市科技发展计划项目(201503020)
关键词 肿瘤大数据 抗肿瘤药物 精准医学 tumor big data anticancer drugs precision medicine
  • 相关文献

参考文献3

二级参考文献45

  • 1蔡长春,李景苏,赵会懂,刘占河.医院药物不良反应监察工作模式的研究与临床实践[J].临床误诊误治,2005,18(5):364-364. 被引量:3
  • 2Zhang W, Bailey-Wilson JE, Li W, et al. Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am J Hum Genet,2000,67:110-119.
  • 3Carter CL, Hu N, Wu M, et al. Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J Natl Cancer Inst, 1992,84 : 771-776.
  • 4Mark SD, Qiao YL, Dawsey SM, et al. Prospective study of serum selenium levels and incident esophageal and gastric caneeas. J Natl Cancer Inst, 2000,92:1753-1763.
  • 5Song CY, Xing DX, Tan W, et al.Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res, 2001, 61 : 3272-3275.
  • 6Miao XP, Xing DY, Tan W, et al. Susceptibility to gastric cardia adenocarcinoma and polymorphisms in methylentetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev,2002,11:1454-1458.
  • 7Stolzenberg-Solomon RZ,Abnet C,Ratnasinghe D, et al.Esophageal/gastric cardia caneer risks and MTRR A66G, MTHFR C677T and MTHFR A1298C polymorphisms in Linxian,China. Proc Am Assoc Cancer Res, 2002,43 : 661.
  • 8Lin DX,Tang YM,Peng Q, et al. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1,P1 ,and M1 and cytochrome p450 2E1. Cancer Epidemiol Biomarkers Prev,1998,7:1013-1018.
  • 9Tan W,Song N,Wang GQ, et al. Impact of genetic polymorphisms in cytochrome p450 2E1 and glutathione S-transferases M1 ,T1,and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prey,2000,9:551-5.56.
  • 10Roth MJ, Dawsey SM, Wang G, et al.Association between GSTM1 * 0 and squamous dysplasia of the esophagus in the high risk region of Linxian,China. Cancer Lett,2000,156:73-81.

共引文献180

同被引文献66

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部